Isoliquiritigenin Inhibits Triple-Negative Breast Cancer Progression via Targeting the IRF5/SLC7A5/IDO1-Mediated Tryptophan Metabolism Pathway.

异甘草素通过靶向 IRF5/SLC7A5/IDO1 介导的色氨酸代谢途径抑制三阴性乳腺癌的进展。